The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review

• Main Authors: Rui Zhang MD, PhD (Author), Xiaotong Sun PhD (Author), Ya Li MD, PhD (Author), Wenzheng He MM (Author), Hongguang Zhu MD, PhD (Author), Baoshan Liu MD, PhD (Author), Aiyuan Zhang MD, PhD (Author)
• Format: Book
• Published: SAGE Publishing, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Heart failure (HF) is one of the leading causes of morbidity and mortality worldwide. Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor, has been approved for the treatment of HF. At present, there have been few systematic and detailed reviews discussing the efficacy and safety of s...